Social Anxiety Disorder
📧 Sign up to get email alerts when something new happens for Social Anxiety Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-02-21FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for an additional generic version of sertraline hydrochloride, expanding the availability of this an…
-
FDA approval · 2019-10-31FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Chartwell RX, LLC)
FDA approved Venlafaxine hydrochloride (extended-release) from Chartwell RX, LLC under an Original Application (ANDA).
-
CLINICAL_TRIALS trial_result · 2019-09-13Clinical Trial Update: Treatment of Social Anxiety Disorder and Selective Mutism [NA]
Clinical trial update for treatment of Social Anxiety Disorder and Selective Mutism; study completed with results posted in 2019.
-
FDA approval · 2019-09-11FDA Approved: PAROXETINE HYDROCHLORIDE — Supplemental Application (Apotex Corp)
FDA supplemental approval granted for Apotex Corp's paroxetine hydrochloride product, approving a generic formulation under NDA 020936.
-
FDA approval · 2019-08-29FDA Approved: VENLAFAXINE — Original Application (Modavar Pharmaceuticals LLC)
FDA approved a generic venlafaxine product from Modavar Pharmaceuticals LLC via an Original Abbreviated New Drug Application (ANDA). The gen…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-08-15Clinical Trial Update: Treatment Study for Rural Latino Youth With Anxiety [Phase 1, Phase 2]
Clinical trial update for a treatment study in rural Latino youth with anxiety, spanning Phase 1 and Phase 2, and completed.
-
FDA approval · 2019-03-29FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Venlafaxine Hydrochloride from Sun Pharmaceutical Industries to support the generic product's co…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Transdiagnostic iCBT for Depression and Anxiety [NA]
This clinical trial update reports on a transdiagnostic internet-based CBT intervention for depression and anxiety disorders, covering major…
-
CLINICAL_TRIALS trial_result · 2019-02-12Clinical Trial Update: Pilot Study: VR Mind and VR Mind+ Intervention [NA]
Pilot clinical trial completion of VR Mind and VR Mind+ interventions for social anxiety disorder (social phobia). Conducted by Tomorrow Sp.…
-
CLINICAL_TRIALS trial_result · 2019-02-07Clinical Trial Update: Brief Shame Intervention Study [NA]
A completed clinical trial evaluating a brief shame intervention. The study targeted Shame and Social Anxiety Disorder and was sponsored by …
-
FDA approval · 2019-01-31FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for sertraline hydrochloride from Rising Pharma Holdings, expanding the availability of a generi…
-
CLINICAL_TRIALS trial_result · 2019-01-30Clinical Trial Update: Promoting Asylum-seeking and Refugee Children's Coping With Trauma [NA]
Clinical trial update documenting the completion of a psychosocial intervention study aimed at helping asylum-seeking and refugee children c…
-
CLINICAL_TRIALS trial_result · 2019-01-23Clinical Trial Update: A Study of the Efficacy of Botox in the Treatment of Social Anxiety Disorder [Phase 4]
A Phase 4 study evaluating onabotulinumtoxinA (Botox) for social anxiety disorder was terminated, and results were posted in January 2019.
-
FDA approval · 2018-11-23FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Marlex Pharmaceuticals, Inc.)
FDA approved a generic venlafaxine hydrochloride product from Marlex Pharmaceuticals, marking the first original ANDA approval for this gene…
-
FDA approval · 2018-11-21FDA Approved: VENLAFAXINE — Original Application (Cadila Pharmaceuticals Limited)
FDA approved the original generic application for venlafaxine from Cadila Pharmaceuticals Limited.
-
CLINICAL_TRIALS trial_result · 2018-10-05Clinical Trial Update: Variations of Cognitive Behavior Therapy for Social Anxiety Disorder [NA]
A completed clinical trial investigating variations of cognitive behavior therapy for Social Anxiety Disorder; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-09-27Clinical Trial Update: Paroxetine for Comorbid Social Anxiety Disorder and Alcoholism [Phase 4]
Phase 4 clinical trial assessing paroxetine for comorbid social anxiety disorder and alcohol use disorders has completed with results posted…
-
CLINICAL_TRIALS trial_result · 2018-09-05Clinical Trial Update: Brief Intervention to Reduce Fear of Public Speaking [Phase 4]
Phase 4 clinical trial evaluating a brief intervention to reduce fear of public speaking in individuals with social anxiety disorder; study …
-
FDA label_change · 2018-08-13FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for venlafaxine hydrochloride filed by Macleods Pharmaceuticals Limited. The approval is associated …
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: Self-Compassion Enhanced CBT vs. Standard CBT for Social Anxiety (SCE-CBT) [NA]
This update reports a completed trial comparing Self-Compassion Enhanced CBT (SCE-CBT) with Standard CBT for Social Anxiety Disorder.
-
CLINICAL_TRIALS trial_result · 2018-06-19Clinical Trial Update: Acceptance-based Self-help for Individuals With Visible Difference and Social Anxiety [NA]
Clinical trial update reporting the completion of a study evaluating Acceptance-based self-help for individuals with visible differences and…
-
FDA approval · 2018-06-12FDA Approved: PAROXETINE — Original Application (Rhodes Pharmaceuticals L.P.)
FDA approved the original abbreviated new drug application for paroxetine hydrochloride hemihydrate from Rhodes Pharmaceuticals, establishin…
-
FDA approval · 2018-05-08FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Accord Healthcare, Inc.)
The FDA approves Accord Healthcare, Inc.'s supplemental application for sertraline hydrochloride (sertraline HCl).
-
CLINICAL_TRIALS research · 2018-04-27Clinical Trial Update: Rumination Focus Cognitive Behavior Therapy [NA]
Clinical trial update on Rumination Focus Cognitive Behavior Therapy for depression and anxiety disorders. The current status is unknown.
-
CLINICAL_TRIALS withdrawal · 2018-04-13Clinical Trial Update: D-Cycloserine and Virtual Reality Exposure Therapy [Phase 2]
A Phase 2 trial combining D-Cycloserine with Virtual Reality Exposure Therapy for Social Anxiety Disorder has been withdrawn.